Publicación:
Enhanced antibiotic resistance as a collateral COVID-19 pandemic effect?

dc.contributor.author Ruiz, J. es_PE
dc.date.accessioned 2024-05-30T23:13:38Z
dc.date.available 2024-05-30T23:13:38Z
dc.date.issued 2021
dc.description.abstract It explains the usefulness of antimicrobials, the actions they carry out to apply them against the spread of COVID-19 and claim the delay generated by the lack of adequate knowledge of the usefulness of antibiotics in the population.
dc.description.sponsorship Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - Concytec
dc.identifier.doi https://doi.org/10.1016/j.jhin.2020.11.010
dc.identifier.uri https://hdl.handle.net/20.500.12390/2800
dc.language.iso eng
dc.publisher Elsevier BV
dc.relation.ispartof JOURNAL OF HOSPITAL INFECTION
dc.rights info:eu-repo/semantics/openAccess
dc.subject Microbiology (medical)
dc.subject Infectious Diseases es_PE
dc.subject General Medicine es_PE
dc.subject.ocde http://purl.org/pe-repo/ocde/ford#3.03.08
dc.title Enhanced antibiotic resistance as a collateral COVID-19 pandemic effect?
dc.type info:eu-repo/semantics/article
dspace.entity.type Publication
Archivos